Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Supportive Care in Cancer

Issue 2/1998

Content (14 Articles)

EDITORIAL

Fatigue and cachexia in cancer patients

Agnes Glaus

Supportive Care News

SUPPORTIVE CARE INTERNATIONAL

Palliative care in India

S. K. Chaturvedi, Prabha S. Chandra

SPECIAL ARTICLE

Parenteral versus enteral nutrition in cancer patients: indications and practice

S. Mercadante

REVIEW ARTICLE

Measuring fatigue in patients with cancer

Alison Richardson

REVIEW ARTICLE

Fatigue, depression and quality of life in cancer patients: how are they related?

M. R. M. Visser, E. M. A. Smets

REVIEW ARTICLE

Pharmacological treatment of cachexia: any progress?

Eduardo Bruera

REVIEW ARTICLE

Supportive care and euthanasia – an ethical dilemma?

Matthias Volkenandt

ORIGINAL ARTICLE

The code of conduct of the volunteer

Claude Fusco-Karmann, Marcello Tamburini, Alessandro Suprani, Amedeo Santosuosso

ORIGINAL ARTICLE

Aerobic and anaerobic infection associated with malignancy

I. Brook, Edith H. Frazier

ORIGINAL ARTICLE

Assessment of the emetogenic potential of intrathecal chemotherapy and response to prophylactic treatment with ondansetron

M. T. Holdsworth, D. W. Raisch, S. S. Winter, C. M. Chavez

ORIGINAL ARTICLE

Different doses of pamidronate in patients with painful osteolytic bone metastases

S. Cascinu, F. Graziano, Paolo Alessandroni, Marco Ligi, Elena Del Ferro, David Rossi, Rita Ficarelli, Giuseppina Catalano

ORIGINAL ARTICLE

Use of mesna to prevent ifosfamide-induced urotoxicity

Lillian L. Siu, M. J. Moore

SHORT COMMUNICATION

Radiochemotherapy with amifostine cytoprotection for head and neck cancer

J. Büntzel, Julius Schuth, Klaus Küttner, Michael Glatzel

Dec 97
Issue: 1/1997
Apr 98
Issue: 3/1998

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits